1 – 5 of 82
- show: 5
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
A preseason booster prolongs the increase of allergen specific IgG4 levels, after basic allergen intralymphatic immunotherapy, against grass pollen seasonal allergy
(
- Contribution to journal › Article
-
Mark
Real-life assessment of chronic rhinosinusitis patients using mobile technology : The mySinusitisCoach project by EUFOREA
(
- Contribution to journal › Article
- 2018
-
Mark
Substance P represents a novel first-line defense mechanism in the nose
(
- Contribution to journal › Article
-
Mark
Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass : A randomized, double-blind, placebo-controlled trial
(
- Contribution to journal › Letter
- 2016
-
Mark
Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial.
(
- Contribution to journal › Article